For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
7
views
68
references
 Top references
cited by
30
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      243
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis.

      Author(s): 1 , 2 , 3 , 4 , 3 , 5 , 6
      Publication date (Electronic):
      Journal: EClinicalMedicine
      Publisher: Elsevier BV
      Keywords: 2vHPV, bivalent HPV vaccine, 4vHPV, quadrivalent HPV vaccine, 9vHPV, 9-valent HPV vaccine, CENTRAL, cochrane central register of controlled trials, CI, confidence interval, CIN2+, cervical intra-epithelial neoplasia grade II, Cervical cancer elimination, EMBASE, excerpta medica dataBASE, GNI, gross national income, HPV vaccine, HPV, human papillomavirus, LMICs, Low- and middle-income countries, Low-and middle-income countries, MSM, men having sex with men, Meta-analysis, RR, relative risk, STROBE, strengthening the reporting of observational studies in epidemiology, Systematic review, US, United States, Vaccine uptake, WHO, World Health Organization

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The proportion of incident cases of HPV-attributable cancers is highest in the low- and middle-income countries (LMICs) but many are yet to initiate HPV vaccination programs. This meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global strategy to eliminate cervical cancer and describes the gaps and challenges.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: not found
          • Article: not found

          Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

          David Moher, Alessandro Liberati, Jennifer Tetzlaff … (2009)
          Article 0 comments Cited 7333 times – based on 0 reviews     Review now
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.

            Damian Hoy, Peter Brooks, Anthony Woolf … (2012)
            In the course of performing systematic reviews on the prevalence of low back and neck pain, we required a tool to assess the risk of study bias. Our objectives were to (1) modify an existing checklist and (2) test the final tool for interrater agreement. The final tool consists of 10 items addressing four domains of bias plus a summary risk of bias assessment. Two researchers tested the interrater agreement of the tool by independently assessing 54 randomly selected studies. Interrater agreement overall and for each individual item was assessed using the proportion of agreement and Kappa statistic. Raters found the tool easy to use, and there was high interrater agreement: overall agreement was 91% and the Kappa statistic was 0.82 (95% confidence interval: 0.76, 0.86). Agreement was almost perfect for the individual items on the tool and moderate for the summary assessment. We have addressed a research gap by modifying and testing a tool to assess risk of study bias. Further research may be useful for assessing the applicability of the tool across different conditions. Copyright © 2012 Elsevier Inc. All rights reserved.
            Article 0 comments Cited 749 times – based on 0 reviews     Review now
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis

              Catherine de Martel, Damien Georges, Freddie Bray … (2019)
              Infectious pathogens are strong and modifiable causes of cancer. The aim of this study was to improve estimates of the global and regional burden of infection-attributable cancers to inform research priorities and facilitate prevention efforts.
              Article 0 comments Cited 551 times – based on 0 reviews     Review now
                Bookmark
                All references

                Author and article information

                Journal
                Journal ID (iso-abbrev): EClinicalMedicine
                Title: EClinicalMedicine
                Publisher: Elsevier BV
                ISSN (Electronic): 2589-5370
                ISSN (Print): 2589-5370
                Publication date (Electronic): Apr 2021
                Volume: 34
                Affiliations
                [1 ] Department of Internal Medicine, Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan.
                [2 ] Kidu Mobile Medical Unit, His Majesty's People's Project, Thimphu, Bhutan.
                [3 ] Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
                [4 ] Department of Obstetrics and Gynaecology, Central Regional Referral Hospital, Gelegphu, Bhutan.
                [5 ] Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
                [6 ] Bumrungrad International Hospital, Bangkok, Thailand.
                Article
                Publisher Item ID: S2589-5370(21)00116-4
                DOI: 10.1016/j.eclinm.2021.100836
                PMC ID: 8102703
                PubMed ID: 33997733
                SO-VID: d8b811f2-7ec6-4728-8261-aa7e56b17517
                History

                Keywords: Vaccine uptake,2vHPV, bivalent HPV vaccine,4vHPV, quadrivalent HPV vaccine,9vHPV, 9-valent HPV vaccine,CENTRAL, cochrane central register of controlled trials,CI, confidence interval,CIN2+, cervical intra-epithelial neoplasia grade II,Cervical cancer elimination,EMBASE, excerpta medica dataBASE,GNI, gross national income,HPV vaccine,HPV, human papillomavirus,LMICs, Low- and middle-income countries,Low-and middle-income countries,MSM, men having sex with men,Meta-analysis,RR, relative risk,STROBE, strengthening the reporting of observational studies in epidemiology,Systematic review,US, United States,WHO, World Health Organization
                Data availability:
                Keywords: Vaccine uptake, 2vHPV, bivalent HPV vaccine, 4vHPV, quadrivalent HPV vaccine, 9vHPV, 9-valent HPV vaccine, CENTRAL, cochrane central register of controlled trials, CI, confidence interval, CIN2+, cervical intra-epithelial neoplasia grade II, Cervical cancer elimination, EMBASE, excerpta medica dataBASE, GNI, gross national income, HPV vaccine, HPV, human papillomavirus, LMICs, Low- and middle-income countries, Low-and middle-income countries, MSM, men having sex with men, Meta-analysis, RR, relative risk, STROBE, strengthening the reporting of observational studies in epidemiology, Systematic review, US, United States, WHO, World Health Organization

                Comments

                Comment on this article

                scite_

                Similar content243

                See all similar

                Cited by30

                See all cited by

                Most referenced authors1,093

                See all reference authors